Abstract 1616: Characterizing differences in checkpoint inhibitor biomarkers in a real-world cohort of stage III and IV non-small cell lung cancer patients

2021 ◽  
Author(s):  
Yinjie Gao ◽  
Michelle M. Stein ◽  
Prerna Jain ◽  
Denise Lau ◽  
Kimberly L. Blackwell ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Checkpoint Inhibitor ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment

2018 ◽  
Vol Volume 10 ◽  
pp. 5537-5544 ◽  
Author(s):  
Stefan Diem ◽  
Mirjam Fässler ◽  
Omar Hasan Ali ◽  
Marco Siano ◽  
Rebekka Niederer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Risk Score ◽  
Cell Lung Cancer ◽  
Checkpoint Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Inhibitor Treatment

Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression

2020 ◽  
Vol 21 (5) ◽  
pp. 389-394.e3
Author(s):  
Thomas E. Stinchcombe ◽  
Rebecca A. Miksad ◽  
Anala Gossai ◽  
Sandra D. Griffith ◽  
Aracelis Z. Torres
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document